A Trial of Setmelanotide in Acquired Hypothalamic Obesity
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
Active, not recruiting · NCT05774756 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of Setmelanotide in Acquired Hypothalamic Obesity | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Froelich syndrome, Male Urogenital Diseases, Urogenital Abnormalities, Urogenital Diseases, disorder of sexual differentiation, endocrine system disorder, gonadal disorder, gonadal dysgenesis, hypogonadism | Active, not recruiting | Phase 3 | 2026-08-10 | NCT05774756 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Rhythm Pharmaceuticals, Inc. | 7 |
28 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.